Premier Biomedical, Inc. (BIEI)

OTCMKTS: BIEI · Delayed Price · USD
0.0020
0.0000 (0.00%)
Jun 24, 2022 4:00 PM EDT - Market closed
0.00%
Market Cap 2.00M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 999.98M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,456,393
Open 0.0019
Previous Close 0.0020
Day's Range 0.0019 - 0.0020
52-Week Range 0.0012 - 0.0072
Beta -4.93
Analysts n/a
Price Target n/a
Earnings Date n/a

About BIEI

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca... [Read more...]

Industry Biotechnology
Founded 2010
CEO William Hartman
Country United States
Stock Exchange OTCMKTS
Ticker Symbol BIEI
Full Company Profile

Financial Performance

In 2019, BIEI's revenue was $14,281, a decrease of -64.11% compared to the previous year's $39,795. Losses were -$374,470, -6.12% less than in 2018.

Financial Statements

News

There is no news available yet.